AMGN Sentiment Analysis

Amgen Inc.: A Promising Investment Option for Dividend Stocks

Published on December 19, 2024

Amgen Inc. (NASDAQ: AMGN) has emerged as one of the best dividend stocks to invest in....

Amgen Inc. Reports Impressive Returns Over Last Three Years

Published on December 18, 2024

Amgen Inc....

Amgen Inc. AMGN: A Promising Investment According to Analysts

Published on December 18, 2024

Amgen Inc. (NASDAQ: AMGN), a multinational biotechnology company, is gaining attention as a lucrative investment option....

Why Amgen Inc. AMGN Is the Best Safe Stock to Buy, According to Analysts

Published on December 17, 2024

Amgen Inc. (AMGN) has been recognized as the best safe stock to buy by experts....

Amgen Inc. Announces Q1 2025 Dividend: 2.38 Per Share Payout for Shareholders

Published on December 16, 2024

Amgen Inc., a leading biotechnology company, recently announced its first-quarter dividend for 2025....

Amgen Inc. Announces Strong Q2 Earnings: Here's What You Need to Know

Published on December 15, 2024

Amgen Inc., a leading biotechnology company, has reported strong financial results for the second quarter of 2025....

Amgen Inc. AMGN: A Trending Stock with Promising Returns

Published on December 14, 2024

Amgen Inc. (NASDAQ: AMGN), a leading biotechnology company, has been making waves in the stock market recently....

Amgen Inc. Continues to Soar as Investors Take Note of Promising Pipelines

Published on December 13, 2024

Amgen Inc. (NASDAQ: AMGN) has caught the attention of investors as it continues to gain momentum in the biotech industry....

Amgen Inc. AMGN: A Promising Stock to Consider, Says Analysts

Published on December 13, 2024

According to recent reports, Amgen Inc. (NASDAQ: AMGN) is being considered as one of the best affordable stocks to buy right now....

Amgen Inc. AMGN: A Promising Investment Opportunity

Published on December 12, 2024

Amgen Inc. (NASDAQ:AMGN) has emerged as one of the best affordable stocks to buy right now....

Amgen Inc. Announces $1 Billion Manufacturing Expansion in North Carolina

Published on December 11, 2024

Amgen Inc....

Why Amgen Inc. AMGN Is Among the Best Affordable Stocks to Buy Right Now

Published on December 10, 2024

Amgen Inc....

Amgen Inc. Expands Manufacturing Operations with a $1 Billion Investment in North Carolina

Published on December 8, 2024

Amgen Inc....

Exciting Developments at Amgen Inc. Prompt Investor Attention

Published on December 5, 2024

Amgen Inc. (NASDAQ: AMGN) has been making waves with its recent actions in the weight loss drug market....

Amgen Inc. Challenges Eli Lilly and Novo Nordisk in Weight Loss Drug Wars

Published on December 3, 2024

Amgen Inc....

Amgen Inc. AMGN is Attracting Investor Attention: Here is What You Should Know

Published on December 3, 2024

Amgen Inc....

Should You Be Excited About Amgen Inc.s NASDAQ:AMGN 56% Return On Equity?

Published on December 2, 2024

Amgen Inc....

Amgen Inc. AMGN: Developing Promising Biotech Innovations

Published on November 29, 2024

Amgen Inc....

AMGEN TO HOST WEBCAST TO DISCUSS MARITIDE PHASE 2 RESULTS AND PROGRESS ON DEVELOPMENT PROGRAM

Published on November 29, 2024

Amgen Inc....

Why Amgen AMGN is a Top Value Stock for the Long-Term

Published on November 28, 2024

Amgen Inc. (AMGN) has established itself as a top value stock for the long-term, according to financial experts....

Daiwa Securities Group Inc. Buys 12932 Shares of Amgen Inc.

Published on November 27, 2024

Amgen Inc., a leading biotechnology company, has recently welcomed a significant investment from Daiwa Securities Group Inc....

Amgen Inc. Announces Appointment of Senior Executive for Research

Published on November 26, 2024

Amgen Inc....

Amgen Inc. offers long-term value and growth potential

Published on November 26, 2024

Amgen Inc. (NASDAQ: AMGN) continues to be a top value stock with promising long-term prospects....

Amgen Inc. AMGN Shows Promising Trends: Here's What You Need to Know

Published on November 25, 2024

Amgen Inc. (NASDAQ: AMGN) has been making significant strides in the biotech sector, attracting attention from investors....

Amgen Inc. Continues to Lead in Immunotherapy: Experts Recommend Investing in Stocks Prognosis

Published on November 24, 2024

Amgen Inc....